Lenmed Health Pty Limited has acquired Sir Albert Medical Center
Lenmed Health Pty Ltd (Lenmed Health) has acquired the business assets of Sir Albert Medical Center (SAMC) comprising the hospital land and buildings, andall other assets and operations of the hospital, including the pharmacy assets and operations located on the land from which SAMC conducts its activities, for US$6 million. Lenmed Health and Harmony Gold have also entered into a 5-year-service-level agreement whereby Lenmed Health will provide medical services to Harmony Gold’s mine patients.
Lenmed Health is an established hospital group in South Africa, operating in South Africa, Mozambique and Botswana, offering more than 1,300 beds.
SAMC is a 100% private hospital providing all medical services. It has a 24 hour casualty department with a doctor on site for immediate assistance.
Harmony Gold, former owner of SAMC, established the hospital to cater for the well being of their mining staff/patients. It is the third largest gold mining company in the world and the third largest gold producer in South Africa. Harmony Gold operates mines in South Africa and Papua New Guinea.
Oaklins' team in South Africa acted as a sponsor and advisor to the buyer in this transaction.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more